NERA Economic Consulting (www.nera.com) is a global firm of experts dedicated to applying economic, finance, and quantitative principles to complex business and legal challenges. For over half a century, NERA's economists have been creating strategies, studies, reports, expert testimony, and policy recommendations for government authorities and the world’s leading law firms and corporations. We bring academic rigor, objectivity, and real world industry experience to bear on issues arising from competition, regulation, public policy, strategy, finance, and litigation.
Cooley's lawyers solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and bet-the-company litigation, often where innovation meets the law. Cooley has 900 lawyers across 13 offices in the United States, China and Europe. Cooley's antitrust & competition team is recognized as one of the top-tier practices in the area of antitrust by Legal 500, Chambers USA and Global Competition Review. We handle all aspects of antitrust and competition law matters – including counseling, litigation, agency representation and arbitration services – for Fortune 500 corporations, as well as growing companies.
Edgeworth Economics provides quantitative and economic consulting in the course of litigation and business to its clients, which include world-class law firms, Fortune 500 companies, and government agencies. Edgeworth experts apply their knowledge and experience, along with state-of-the-art computing infrastructure, to help clients efficiently manage complex issues including antitrust litigation, privacy & data security, transfer pricing, intellectual property, mergers and acquisitions, class actions, labor, and data & HR analytics. As a rapidly growing firm with a fresh approach, Edgeworth attracts leaders and teachers from across the industry including PhD economists, MBAs, statisticians, and programmers. Edgeworth has offices in Washington, DC, Pasadena, San Francisco, and Toronto.
Dr. Claire Chunying Xie is a Senior Consultant in NERA’s Antitrust, Intellectual Property, and Life Science Practices, where she conducts economic analysis in the areas of antitrust, intellectual property, and commercial damages. In antitrust matters, Dr. Xie has evaluated the competitive effects of mergers and acquisitions, and has analyzed antitrust claims and damages in cases involving alleged monopolization and price fixing behavior. Her project experience in antitrust matters spans a wide variety of industries including agriculture, data management, finance, fuel retailing, pharmaceuticals, and telecommunications. In the area of intellectual property, Dr. Xie has calculated lost profit and reasonable royalty damages in cases involving patent infringement and breach of contract allegations in industries such as apparel, credit cards, and pharmaceuticals. Dr. Xie received her PhD and MA in economics from the University of Minnesota, Twin Cities, where she also taught microeconomics, macroeconomics, money and banking, and Chinese economy. She received her BA in economics and mathematics, summa cum laude, from Agnes Scott College.
Jacqueline Grise is chair of Cooley's antitrust and competition practice group. Her practice focuses on the defense of corporate clients in connection with domestic and international mergers and acquisitions, as well as antitrust counseling and other non-merger matters. She regularly represents clients before the FTC, the DOJ and numerous foreign antitrust enforcement agencies. Jackie has extensive experience counseling clients through the HSR merger review process, including advocating before the agencies, responding to second requests and coordinating antitrust defense strategies in countries around the world. Her clients span a broad range of industries, including life sciences, pharmaceuticals, medical devices, technology, consumer and food products, computer and data storage, media, industrial equipment, retail, and aerospace. She currently serves as a Vice-Chair of the ABA Antitrust Healthcare and Pharmaceuticals Committee and is co-editor of the ABA Antitrust Section’s book entitled Antitrust Aspects of the Pharmaceutical Industry (2nd).
Dr. Korenko specializes in the economics of antitrust, tax and transfer pricing, labor and executive compensation, intellectual property, and housing finance. He also specializes in the application of statistical analysis to these areas. In antitrust, Dr. Korenko has conducted economic and statistical analyses of class certification and liability issues, and prepared analyses of antitrust impact and damages. He has analyzed economic issues related to allegations of price fixing, bid rigging, tying, and monopolization, and has provided expert testimony in Federal District Court and in arbitrations. Dr. Korenko has analyzed these issues in a number of industries, including life sciences, health care, financial products, electronic components, automobile parts, railroads, and chemicals.